Texas Ozempic Lawsuit Attorney

A study by JAMA Ophthalmology of more than 16,000 semaglutide patients had a significantly higher risk of developing nonarteritic anterior ischemic optic nerve damage compared with those on other drugs. Further evidence from a case report of bilateral NAION following weight loss on semaglutide illustrates how nonarteritic anterior ischemic optic neuropathy appears in real-world use. Additionally, a BMC Ophthalmology review described four NAION case reports in patients taking semaglutide drugs. This raised concerns about the flow to the optic nerve.

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee concluded that non-arteritic anterior ischemic optic neuropathy (NAION) is a very rare side effect of semaglutide medication and required warning label changes advising to stop taking Ozempic if vision problems occur.

The American Academy of Ophthalmology reports that semaglutide drugs can cause blurred vision and may worsen diabetic retinopathy. Supporting this, the SUSTAIN-6 cardiovascular outcomes trial found that once-weekly semaglutide drugs carry a higher risk of diabetic retinopathy progression.

If you suffered vision loss or other severe side effects after taking Ozempic, you may qualify to file a lawsuit. Our Texas Ozempic vision loss lawsuit attorney team is currently reviewing Ozempic cases where patients experienced sudden vision loss, worsening vision problems, or were later declared legally blind. Many non-arteritic anterior ischemic optic neuropathy (NAION) claims involve disruption of blood flow to the optic nerve. NAION occurs when circulation or blood flow to the optic nerve is reduced or blocked. Reviews have linked permanent vision loss to semaglutide drugs, like Ozempic.

To file an Ozempic vision loss lawsuit in Texas, patients prescribed Ozempic must show their use of Ozempic was as their doctor ordered and that they later suffered vision loss. You must have a doctor’s diagnosis confirming irreversible vision loss or non-arteritic anterior ischemic optic neuropathy (NAION). Ozempic users who are legally blind due to optic nerve damage have the strongest NAION claims.

Ozempic vision loss lawsuits allege that the defendant, Novo Nordisk, failed to warn patients and healthcare providers of the higher risks of vision loss, despite evidence that NAION claims were foreseeable and preventable.

Our Ozempic vision loss lawsuit attorneys provide skilled Texas vision loss claim assistance. Our Texas Ozempic vision loss lawyers confirm the diagnosis of vision loss, nonarteritic anterior ischemic optic neuropathy, or worsening diabetic retinopathy, and ensure the vision loss is linked to Ozempic use.

The Ozempic vision loss lawsuit process can include filing a lawsuit individually or in New Jersey state court, where more plaintiffs allege that Novo Nordisk and Eli Lilly didn’t properly warn about permanent or sudden vision loss.

If you or a loved one experienced vision problems after taking Ozempic, including sudden vision loss, irreversible vision loss, or a diagnosis of nonarteritic anterior ischemic optic neuropathy, you may be able to file a lawsuit. Contact a Texas Ozempic vision loss lawsuit attorney for a free consultation.

The EMA and FDA added acute pancreatitis as a known risk to the Ozempic warning label. Clinical trials have found similar rates of acute pancreatitis in semaglutide users. A Cureus case report documented a patient who developed drug-induced pancreatitis shortly after semaglutide use. The Cleveland Clinic Journal of Medicine also highlights that while GLP‑1 receptor agonists are effective for diabetes and weight loss, they may slightly increase the health risk of drug-induced pancreatitis

If you or a loved one developed severe pancreatitis after taking Ozempic, you may be eligible to file an Ozempic lawsuit. Call our Texas Ozempic attorney team for a free case review.

More plaintiffs have filed Ozempic gastroparesis lawsuits than any other Ozempic injuries. Semaglutide medications have been subject to numerous gastric emptying studies. J Investigative Medicine High Impact Case Reports described gastroparesis (stomach paralysis) from semaglutide use. Diabetes, Obesity and Metabolism found that semaglutide, the active ingredient in many GLP-1 drugs, like Ozempic, delayed gastric emptying. Also, a comparative study in Obesity reported a higher incidence of stomach paralysis in obese patients taking semaglutide. Such medical news demonstrates that delayed gastric emptying leads to gastroparesis (stomach paralysis). The FDA added stomach paralysis to the Ozempic label. Over 1,800 Ozempic gastroparesis lawsuits and bowel obstruction claims have been consolidated in the Ozempic MDL.

If you developed severe gastroparesis (stomach paralysis), or required hospitalization for severe dehydration, persistent vomiting, or suffered pulmonary aspiration complications after taking Ozempic, you can potentially pursue a gastroparesis claim. a Texas Ozempic gastroparesis lawsuit attorney. Our law firm can help you seek financial compensation through the Ozempic multidistrict litigation (MDL).

Chronic abdominal pain is a red-flag symptom. Persistent vomiting and severe abdominal pain often indicate serious gastrointestinal injuries. Severe gastrointestinal injury claims linked to Ozempic typically include:

• Gastroparesis (stomach paralysis): Some Ozempic users suffer severe gastroparesis (stomach paralysis), where the digestive system no longer moves food properly, causing severe vomiting and early fullness.
• Dehydration from severe vomiting: Persistent vomiting can lead to severe dehydration, malnutrition, kidney problems, fainting, and hospitalization for IV treatment.
• Severe constipation: Intestinal problems from constipation linked to the use of Ozempic can cause swelling, stomach pain, and secondary but serious complications.
• Gastrointestinal burning and acid reflux: Patients may experience chronic heartburn, gastrointestinal burning in the chest or throat, and esophageal damage from prolonged acid reflux.
• Organ injuries related to prolonged gastrointestinal issues: Gastrointestinal issues can cause kidney, liver, or other organ injuries.

If you experienced severe gastroparesis, abdominal pain, acid reflux, organ damage, or other gastrointestinal issues after taking Ozempic. You may be eligible to join the Ozempic class action lawsuit. Consult a Texas Ozempic lawsuit attorney from our law firm for a free case review.

Gastrointestinal issues, like intestinal obstruction and intestinal blockage, occur when food intake and waste can’t move properly. Plaintiffs continue to complain about stomach pain, persistent vomiting, and inflammation before their doctor diagnosed gastroparesis or severe intestinal blockages. Without treatment, intestinal obstruction can cut off blood flow, and intestinal blockages are life-threatening. Many patients taking Ozempic went to the emergency room and required surgery to remove intestinal blockages. Intestinal blockages and obstructions tied to the diabetes medication include:

• Small intestinal blockages: When food sits too long in the stomach, it can enter the small intestine in undigested chunks. This can cause severe vomiting of bile, cramping, and bloating.
• Bezoar-related intestinal obstructions: Undigested food clumps into hard masses. These get stuck, causing intestinal blockages in the small intestine.
• Functional pseudo-intestinal obstructions: The small intestine shuts down without a physical mass. This can produce the same side effects as intestinal blockages, like stomach pain, swelling, and severe vomiting.
• Large intestinal blockages: Severe constipation can harden into stool that blocks the colon
• Fecal impaction: Intestinal obstruction caused by hardened stools.
• Colonic pseudo-intestinal obstruction: Intestinal blockage caused by colon decline. If not treated quickly, bowel obstructions can rupture the bowel.

If you developed intestinal blockages or intestinal obstruction, like bowel obstruction, or developed another gastrointestinal disorder after taking Ozempic, you may be able to file a lawsuit.

Strong gastrointestinal injury and gastroparesis claims often involve:

• Hospitalization for bowel obstruction
• Surgery to remove intestinal blockages or repair severe GI injuries
• Medical records showing diagnosis of intestinal blockage, impaction, or pseudo-intestinal obstruction
• Ongoing health issues caused by prolonged gastrointestinal issues

Our Texas Ozempic lawsuit attorneys can help you file an Ozempic lawsuit individually or help you join the class action lawsuit. We’ll demonstrate that Novo Nordisk failed to warn patients, like you, about the health risks of intestinal blockages, and ensure you get your part of the global settlement.

Patients taking Ozempic have experienced gallbladder disease and gallstones. Some required gallbladder removal surgery (cholecystectomy). Research indicates that GLP-1 receptor agonists, such as semaglutide drugs, can lead to potential complications. JAMA Internal Medicine found that GLP-1 receptor agonists were associated with a higher risk of gallbladder or biliary diseases. A Diabetology & Metabolic Syndrome study reported that GLP-1 drugs significantly delayed gallbladder emptying, increasing the chance of gallbladder disease. The FDA added acute gallbladder disease and gallstones to the Ozempic warning label. The warning label instructs physicians to evaluate those with upper abdominal pain, fever, jaundice, or clay-colored stools.

Many patients have required emergency gallbladder removal surgery after developing gallbladder disease or gallstones. Plaintiffs filed lawsuits alleging that Novo Nordisk and Eli Lilly didn’t properly warn about the frequency or severity of gallbladder disease, despite strong scientific evidence.

If you developed gallstones, gallbladder disease, or required gallbladder removal after using Ozempic, you may be eligible to file an Ozempic gallbladder lawsuit. A Texas Ozempic lawsuit attorney can help you pursue financial compensation. Because claims related to gallbladder disease and similar severe injuries are being heard through ongoing Ozempic litigation, filing a lawsuit positions your Ozempic case for a potential global settlement.

The Endocrine Journal reported that people taking Ozempic or other semaglutide medications were more than three times as likely to develop deep vein thrombosis (DVT). These potential complications are caused by side effects of Ozempic, like severe dehydration and blood clotting risks. A Journal of the American Heart Association review showed that GLP-1 drugs showed a significantly increased risk of deep vein thrombosis. However, pulmonary embolisms didn’t increase at this rate.

A pulmonary embolism occurs when a blood clot, most often in the legs, travels to the lungs and blocks blood flow. Pulmonary embolisms can be life-threatening if left untreated. Because DVT is the most common source of pulmonary embolisms, this raises concerns about PE as well.

The Ozempic warning label doesn’t list blood clots, deep vein thrombosis, or pulmonary embolism.

Given clinical signals of deep vein thrombosis (DVT) and the absence of blood clot-related issues on the Ozempic warning label, people harmed may allege failure to warn. Since the ongoing Ozempic litigation excludes blood clot claims, these Ozempic claims must be filed by individual plaintiffs.

If you suffered cardiac arrest, a blood clot, deep vein thrombosis, or a pulmonary embolism after taking Ozempic, contact a Texas Ozempic lawsuit attorney to discuss taking legal action.

There are numerous individuals involved in case reports of acute kidney injury from Ozempic and other GLP-1 receptor agonists. Kidney Medicine describes two patients with diabetic kidney disease who rapidly declined after taking GLP-1 drugs. Stopping medication was needed to stabilize renal function.

Another patient developed acute interstitial nephritis after a semaglutide dose increase, a life-threatening condition. Another case re

Doctors have also seen patients develop rare kidney diseases that damage kidney filters after taking Ozempic. This shows that the diabetes drug isn’t only linked to kidney problems from dehydration. This links Ozempic to immune system attacks that target the kidneys directly. Additionally, drugs like Ozempic have been connected with hundreds of hospital stays for sudden kidney failure.

Serious health complications related to kidney damage aren’t hypothetical. These are serious complications suffered by hundreds of patients who trusted medications manufactured by Novo Nordisk.

If you developed acute kidney injury, interstitial nephritis, or required dialysis after being prescribed Ozempic, contact a Texas Ozempic lawsuit attorney for a free case review.

Pulmonary aspiration is when food or stomach contents enter the lungs, most often during general anesthesia or deep sedation.

The Canadian Journal of Anesthesia conducted a gastric emptying study, documenting that slower gastric emptying led to pulmonary aspiration during general anesthesia or deep sedation. The UK Medicines and Healthcare products Regulatory Agency warned that Ozempic and other GLP-1 receptor agonists have been linked to pulmonary aspiration during surgery. Other researchers found that patients taking GLP-1 drugs had a 33% higher rate of aspiration pneumonia following endoscopy.

Other countries warned of this. However, the Food and Drug Administration has not added this health risk to the Ozempic warning label. Because pulmonary aspiration is not disclosed on the Ozempic label, plaintiffs may argue failure to warn.

We can help victims file lawsuits if they:

• were prescribed Ozempic or another semaglutide drug,
• experienced pulmonary aspiration during general anesthesia or deep sedation,
• have medical documentation showing aspiration pneumonia, airway obstruction, or emergency intervention from pulmonary aspiration, and
• can show financial or physical harm.

Contact a Texas Ozempic lawsuit attorney for a free consultation to discuss your legal options for seeking financial compensation.

Patients taking Ozempic have reported psychiatric side effects. What are the Ozempic mental health side effects? The Ozempic side effects related to mental health include depression, anxiety, and suicidal thoughts. A psychiatric analysis of adverse events showed how semaglutide medications were linked to depression and suicidal ideation. Some were fatal. Other research found that patients taking GLP-1 receptor agonists had nearly double the health risk of developing psychiatric disorders. This included a 195% higher risk for major depression, along with increased risk of anxiety and suicidal behavior. A WHO database analysis found a 45% higher rate of reported suicidal ideation with the use of Ozempic or semaglutide compared with other diabetes drugs.

Psychiatric side effects are not listed anywhere on the current FDA Ozempic warning label. Because Novo Nordisk, which manufactures Ozempic, didn’t adequately warn patients of psychiatric side effects, patients may argue failure to warn.

If you were prescribed Ozempic and developed depression, suicidal ideation, or attempted suicide, you may be eligible to file an Ozempic lawsuit. Claims related to psychiatric side effects are strongest when health issues emerged after taking Ozempic and resolved when the diabetes medication was discontinued.

These aren’t part of the current Ozempic litigation. Our Texas Ozempic lawsuit attorneys can help you file an Ozempic lawsuit individually or at the state level. We are currently monitoring for these to occur in the Ozempic MDL. For skilled Texas psychiatric claim assistance, contact our legal team.

Drug makers never tested GLP-1 drugs in pregnancy. Upon FDA approval, the Ozempic warning label states that semaglutide may cause harm to the fetus and that women should stop the diabetes drug at least two months before planning a pregnancy. The European Medicines Agency likewise advises against using semaglutide during pregnancy. Despite this, patients have reported they were not properly warned by healthcare providers.

If you took Ozempic during pregnancy and your baby was born with defects, delays, or if you experienced miscarriage or stillbirth, you may be able to file an Ozempic lawsuit. There isn’t a class action lawsuit for pregnancy harms or “Ozempic babies”. Our law firm is monitoring whether coordinated Ozempic litigation will develop. Since the drug company did adequately warn, plaintiffs’ lawyers may argue that healthcare providers didn’t adequately warn their patients of these health issues.

For skilled Texas birth injury claims assistance, contact our law firm for a free case review.

Ozempic wrongful death claims are being investigated. The Ozempic warning label doesn’t list death. The FDA’s Adverse Event Reporting System has documented patient deaths linked to semaglutide, often tied to pancreatitis, intestinal blockage, or pulmonary aspiration pneumonia during surgeries. The European Medicines Agency has also confirmed that fatal outcomes have been reported.

Intestinal blockage, aspiration, or gastroperis claims tied to wrongful death are strongest when hospital records, autopsy results, or physician notes connect semaglutide use to the fatal event. Wrongful death claims aren’t included in the multi-district litigation (MDL). So families must file Ozempic lawsuits individually or at the state level. Our Texas Ozempic lawsuit attorneys are watching to determine whether enough cases could lead to an expansion in product liability litigation or a separate Ozempic MDL.

We provide Texas wrongful death claims assistance for both weight loss and diabetes use. Contact a Texas Ozempic death lawyer for a free consultation to discuss your legal options.